4.1 Article

Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis

Journal

BMJ CASE REPORTS
Volume 13, Issue 7, Pages -

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/bcr-2020-236815

Keywords

haematology (incl blood transfusion); infectious diseases

Ask authors/readers for more resources

We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reasonable to evoke ITP in case of profound thrombocytopaenia in a patient with COVID-19.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available